These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3821430)

  • 1. Importance of valid measurements of benefit and risk.
    Spitzer WO
    Med Toxicol; 1986; 1 Suppl 1():74-8. PubMed ID: 3821430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of scientific evidence of risks and benefits in determining risk management policies for medications.
    Andrews E; Dombeck M
    Pharmacoepidemiol Drug Saf; 2004 Sep; 13(9):599-608. PubMed ID: 15362082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma.
    Eichler HG; Pignatti F; Flamion B; Leufkens H; Breckenridge A
    Nat Rev Drug Discov; 2008 Oct; 7(10):818-26. PubMed ID: 18787530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cutaneous side-effects in drug assessment].
    Jean-Pastor MJ
    Therapie; 2002; 57(3):265-8. PubMed ID: 12422540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Criteria supporting the study of drugs in the newborn.
    Ward RM; Benitz WE; Benjamin DK; Blackmon L; Giacoia GP; Hudak M; Lasky T; Rodriguez W; Selen A
    Clin Ther; 2006 Sep; 28(9):1385-98. PubMed ID: 17062311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug related hospital admissions in subspecialities of internal medicine.
    Hallas J
    Dan Med Bull; 1996 Apr; 43(2):141-55. PubMed ID: 8741207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing therapeutic benefit and risk.
    Meyboom RH; Egberts AC
    Therapie; 1999; 54(1):29-34. PubMed ID: 10216419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing approaches to assessment of environmental inhalation risk: a case study.
    Corn JK; Corn M
    Milbank Q; 1995; 73(1):97-119. PubMed ID: 7898410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate prescribing in the older population: need for new criteria.
    O'Mahony D; Gallagher PF
    Age Ageing; 2008 Mar; 37(2):138-41. PubMed ID: 18349010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future of toxicology--low-dose toxicology and risk--benefit analysis.
    Rietjens IM; Alink GM
    Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The challenge of drug-rechallenge: Facts and controversies.
    Davidovici BB; Wolf R
    Clin Dermatol; 2010; 28(3):349-53. PubMed ID: 20541691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval.
    Borer JS; Pouleur H; Abadie E; Follath F; Wittes J; Pfeffer MA; Pitt B; Zannad F
    Eur Heart J; 2007 Aug; 28(15):1904-9. PubMed ID: 17615083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic assessment of risks of adverse reactions associated with intermittent exposure.
    Feldmann U
    Biometrics; 1993 Jun; 49(2):419-28. PubMed ID: 8369378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New evidence-based criteria for evaluating the appropriateness of drug regimen in seniors. Criteria STOPP (screening tool of older person's prescriptions) and START (screening tool to alert doctors to right treatment)].
    Topinková E; Mádlová P; Fialová D; Klán J
    Vnitr Lek; 2008 Dec; 54(12):1161-9. PubMed ID: 19140525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.